<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36495857</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>21</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2213-1582</ISSN><JournalIssue CitedMedium="Internet"><Volume>37</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>NeuroImage. Clinical</Title><ISOAbbreviation>Neuroimage Clin</ISOAbbreviation></Journal><ArticleTitle>Distinct hypothalamic involvement in the amyotrophic lateral sclerosis-frontotemporal dementia spectrum.</ArticleTitle><Pagination><StartPage>103281</StartPage><MedlinePgn>103281</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">103281</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.nicl.2022.103281</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2213-1582(22)00346-1</ELocationID><Abstract><AbstractText Label="BACKGROUND">Hypothalamic dysregulation plays an established role in eating abnormalities in behavioural variant frontotemporal dementia (bvFTD) and amyotrophic lateral sclerosis (ALS). Its contribution to cognitive and behavioural impairments, however, remains unexplored.</AbstractText><AbstractText Label="METHODS">Correlation between hypothalamic subregion atrophy and cognitive and behavioural impairments was examined in a large sample of 211 participants (52 pure ALS, 42 mixed ALS-FTD, 59 bvFTD, and 58 age- and education- matched healthy controls).</AbstractText><AbstractText Label="RESULTS">Graded variation in hypothalamic involvement but relative sparing of the inferior tuberal region was evident across all patient groups. Bilateral anterior inferior, anterior superior, and posterior hypothalamic subregions were selectively implicated in memory, fluency and processing speed impairments in addition to apathy and abnormal eating habits, taking into account disease duration, age, sex, total intracranial volume, and acquisition parameters (all p&#xa0;&#x2264;&#xa0;.001).</AbstractText><AbstractText Label="CONCLUSIONS">These findings revealed that subdivisions of the hypothalamus are differentially affected in the ALS-FTD spectrum and contribute to canonical cognitive and behavioural disturbances beyond eating abnormalities. The anterior superior and superior tuberal subregions containing the paraventricular nucleus (housing oxytocin-producing neurons) displayed the greatest volume loss in bvFTD and ALS-FTD, and ALS, respectively. Importantly, the inferior tuberal subregion housing the arcuate nucleus (containing different groups of neuroendocrine neurons) was selectively preserved across the ALS-FTD spectrum, supporting pathophysiological findings of discrete neuropeptide expression abnormalities that may underlie the pathogenesis of autonomic and metabolic abnormalities and potentially certain cognitive and behavioural symptom manifestations, representing avenues for more refined symptomatic treatment targets.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 The Author(s). Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tse</LastName><ForeName>Nga Yan</ForeName><Initials>NY</Initials><AffiliationInfo><Affiliation>The University of Sydney, Brain &amp; Mind Centre, Sydney, Australia; Royal Prince Alfred Hospital, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bocchetta</LastName><ForeName>Martina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Todd</LastName><ForeName>Emily G</ForeName><Initials>EG</Initials><AffiliationInfo><Affiliation>Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Devenney</LastName><ForeName>Emma M</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>The University of Sydney, Brain &amp; Mind Centre, Sydney, Australia; Royal Prince Alfred Hospital, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tu</LastName><ForeName>Sicong</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>The University of Sydney, Brain &amp; Mind Centre, Sydney, Australia; Royal Prince Alfred Hospital, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caga</LastName><ForeName>Jashelle</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>The University of Sydney, Brain &amp; Mind Centre, Sydney, Australia; Royal Prince Alfred Hospital, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hodges</LastName><ForeName>John R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>The University of Sydney, Brain &amp; Mind Centre, Sydney, Australia; Royal Prince Alfred Hospital, Sydney, Australia; The University of Sydney, School of Psychology and Brain &amp; Mind Centre, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Halliday</LastName><ForeName>Glenda M</ForeName><Initials>GM</Initials><AffiliationInfo><Affiliation>The University of Sydney, Sydney Medical School and Brain &amp; Mind Centre, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Irish</LastName><ForeName>Muireann</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>The University of Sydney, School of Psychology and Brain &amp; Mind Centre, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kiernan</LastName><ForeName>Matthew C</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>The University of Sydney, Brain &amp; Mind Centre, Sydney, Australia; Royal Prince Alfred Hospital, Sydney, Australia; The University of Sydney, Sydney Medical School and Brain &amp; Mind Centre, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piguet</LastName><ForeName>Olivier</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>The University of Sydney, School of Psychology and Brain &amp; Mind Centre, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rohrer</LastName><ForeName>Jonathan D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmed</LastName><ForeName>Rebekah M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>The University of Sydney, Brain &amp; Mind Centre, Sydney, Australia; Royal Prince Alfred Hospital, Sydney, Australia; Memory and Cognition Clinic, Institute of Clinical Neurosciences, Royal Prince Alfred Hospital, Sydney, Australia. Electronic address: Rebekah.ahmed@sydney.edu.au.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MR/M008525/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/M023664/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/T046015/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>BRC149/NS/MH</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Neuroimage Clin</MedlineTA><NlmUniqueID>101597070</NlmUniqueID><ISSNLinking>2213-1582</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057565" MajorTopicYN="Y">Apathy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005247" MajorTopicYN="N">Feeding Behavior</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007031" MajorTopicYN="N">Hypothalamus</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Cognitive and behavioural impairment</Keyword><Keyword MajorTopicYN="N">Frontotemporal dementia</Keyword><Keyword MajorTopicYN="N">Hypothalamus</Keyword><Keyword MajorTopicYN="N">Neuroimaging</Keyword><Keyword MajorTopicYN="N">Neuropathophysiology</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>11</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>10</Day><Hour>18</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36495857</ArticleId><ArticleId IdType="pmc">PMC9731897</ArticleId><ArticleId IdType="doi">10.1016/j.nicl.2022.103281</ArticleId><ArticleId IdType="pii">S2213-1582(22)00346-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ahmed R.M., Latheef S., Bartley L., et al. Eating behavior in frontotemporal dementia. Neurology. 2015;85(15):1310&#x2013;1317. doi: 10.1212/WNL.0000000000002018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000002018</ArticleId><ArticleId IdType="pmc">PMC4617167</ArticleId><ArticleId IdType="pubmed">26377252</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed R.M., Devenney E.M., Irish M., et al. Neuronal network disintegration: common pathways linking neurodegenerative diseases. J. Neurol. Neurosurg. Psychiatry. 2016;87(11):1234&#x2013;1241. doi: 10.1136/jnnp-2014-308350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2014-308350</ArticleId><ArticleId IdType="pmc">PMC5099318</ArticleId><ArticleId IdType="pubmed">27172939</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed R.M., Highton-Williamson E., Caga J., et al. Lipid metabolism and survival across the frontotemporal dementia-amyotrophic lateral sclerosis spectrum: relationships to eating behavior and cognition. J. Alzheimer&#x2019;s Dis. 2017;61(2):773&#x2013;783. doi: 10.3233/JAD-170660.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-170660</ArticleId><ArticleId IdType="pubmed">29254092</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed R.M., Tse N.Y., Chen Y., et al. Neural correlates of fat preference in frontotemporal dementia: translating insights from the obesity literature. Ann. Clin. Transl. Neurol. 2021;8(6):1318&#x2013;1329. doi: 10.1002/acn3.51369.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51369</ArticleId><ArticleId IdType="pmc">PMC8164857</ArticleId><ArticleId IdType="pubmed">33973740</ArticleId></ArticleIdList></Reference><Reference><Citation>Atasoy D., Nicholas Betley J., Su H.H., Sternson S.M. Deconstruction of a neural circuit for hunger. Nature. 2012;488(7410):172&#x2013;177. doi: 10.1038/nature11270.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11270</ArticleId><ArticleId IdType="pmc">PMC3416931</ArticleId><ArticleId IdType="pubmed">22801496</ArticleId></ArticleIdList></Reference><Reference><Citation>Billot B., Bocchetta M., Todd E., Dalca A.V., Rohrer J.D., Iglesias J.E. Automated segmentation of the hypothalamus and associated subunits in brain MRI. Neuroimage. 2020;223(May) doi: 10.1016/j.neuroimage.2020.117287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2020.117287</ArticleId><ArticleId IdType="pmc">PMC8417769</ArticleId><ArticleId IdType="pubmed">32853816</ArticleId></ArticleIdList></Reference><Reference><Citation>Bocchetta M., Gordon E., Manning E., et al. Detailed volumetric analysis of the hypothalamus in behavioral variant frontotemporal dementia. J. Neurol. 2015;262(12):2635&#x2013;2642. doi: 10.1007/s00415-015-7885-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-015-7885-2</ArticleId><ArticleId IdType="pmc">PMC4655011</ArticleId><ArticleId IdType="pubmed">26338813</ArticleId></ArticleIdList></Reference><Reference><Citation>Bocchetta M., Todd E.G., Peakman G., et al. Differential early subcortical involvement in genetic FTD within the GENFI cohort. Neuroimage Clin. 2021;30(March):8&#x2013;11. doi: 10.1016/j.nicl.2021.102646.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2021.102646</ArticleId><ArticleId IdType="pmc">PMC8099608</ArticleId><ArticleId IdType="pubmed">33895632</ArticleId></ArticleIdList></Reference><Reference><Citation>Bocchetta M., Todd E.G., Tse N.Y., et al. Thalamic and cerebellar regional involvement across the ALS&#x2013;FTD spectrum and the effect of C9orf72. Brain Sci. 2022;12(3):1&#x2013;16. doi: 10.3390/brainsci12030336.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci12030336</ArticleId><ArticleId IdType="pmc">PMC8945983</ArticleId><ArticleId IdType="pubmed">35326292</ArticleId></ArticleIdList></Reference><Reference><Citation>Buckner R.L., Andrews-Hanna J.R., Schacter D.L. The brain&#x2019;s default network: anatomy, function, and relevance to disease. Ann. NY Acad. Sci. 2008;1124:1&#x2013;38. doi: 10.1196/annals.1440.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1196/annals.1440.011</ArticleId><ArticleId IdType="pubmed">18400922</ArticleId></ArticleIdList></Reference><Reference><Citation>Burrell J.R., Halliday G.M., Kril J.J., et al. The frontotemporal dementia-motor neuron disease continuum. Lancet. 2016;388(10047):919&#x2013;931. doi: 10.1016/S0140-6736(16)00737-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(16)00737-6</ArticleId><ArticleId IdType="pubmed">26987909</ArticleId></ArticleIdList></Reference><Reference><Citation>Cedarbaum J.M., Stambler N., Malta E., et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. J. Neurol. Sci. 1999;169(1&#x2013;2):13&#x2013;21. doi: 10.1016/S0022-510X(99)00210-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(99)00210-5</ArticleId><ArticleId IdType="pubmed">10540002</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xc7;oban A., Bilgi&#xe7; B., Lohmann E., et al. Reduced orexin-a levels in frontotemporal dementia: possible association with sleep disturbance. Am. J. Alzheimer&#x2019;s Dis. Other Demen. 2013;28(6):606&#x2013;611. doi: 10.1177/1533317513494453.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1533317513494453</ArticleId><ArticleId IdType="pubmed">23813609</ArticleId></ArticleIdList></Reference><Reference><Citation>Coll A.P., Farooqi I.S., O&#x2019;Rahilly S. The hormonal control of food intake. Cell. 2007;129(2):251&#x2013;262. doi: 10.1016/j.cell.2007.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2007.04.001</ArticleId><ArticleId IdType="pmc">PMC2202913</ArticleId><ArticleId IdType="pubmed">17448988</ArticleId></ArticleIdList></Reference><Reference><Citation>Cykowski M.D., Takei H., Schulz P.E., Appel S.H., Powell S.Z. TDP-43 pathology in the basal forebrain and hypothalamus of patients with amyotrophic lateral sclerosis. Acta Neuropathol. Commun. 2014;2(1):1&#x2013;11. doi: 10.1186/s40478-014-0171-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-014-0171-1</ArticleId><ArticleId IdType="pmc">PMC4297460</ArticleId><ArticleId IdType="pubmed">25539830</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L., Corcia P., Fergani A., et al. Dyslipidemia is a protective factor in amyotrophic lateral sclerosis.pdf. Published online. 2008 doi: 10.1212/01.wnl.0000285080.70324.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000285080.70324</ArticleId><ArticleId IdType="pubmed">18199832</ArticleId></ArticleIdList></Reference><Reference><Citation>Finger E.C., MacKinley J., Blair M., et al. Oxytocin for frontotemporal dementia: a randomized dose-finding study of safety and tolerability. Neurology. 2015;84(2):174&#x2013;181. doi: 10.1212/wnl.0000000000001133.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.0000000000001133</ArticleId><ArticleId IdType="pmc">PMC4336088</ArticleId><ArticleId IdType="pubmed">25503617</ArticleId></ArticleIdList></Reference><Reference><Citation>Gabery S., Ahmed R.M., Caga J., Kiernan M.C., Halliday G.M., Peters&#xe9;n &#xc5;. Loss of the metabolism and sleep regulating neuronal populations expressing orexin and oxytocin in the hypothalamus in amyotrophic lateral sclerosis. Neuropathol. Appl. Neurobiol. 2021;47(7):979&#x2013;989. doi: 10.1111/nan.12709.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12709</ArticleId><ArticleId IdType="pubmed">33755993</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorges M., Vercruysse P., M&#xfc;ller H.P., et al. Hypothalamic atrophy is related to body mass index and age at onset in amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry. 2017;88(12):1033&#x2013;1041. doi: 10.1136/jnnp-2017-315795.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-315795</ArticleId><ArticleId IdType="pubmed">28596251</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsieh S., Schubert S., Hoon C., Mioshi E., Hodges J.R. Validation of the Addenbrooke&#x2019;s cognitive examination III in frontotemporal dementia and Alzheimer&#x2019;s disease. Dement. Geriatr. Cognit. Disord. 2013;36(3&#x2013;4):242&#x2013;250. doi: 10.1159/000351671.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000351671</ArticleId><ArticleId IdType="pubmed">23949210</ArticleId></ArticleIdList></Reference><Reference><Citation>Jesso S., Morlog D., Ross S., et al. The effects of oxytocin on social cognition and behaviour in frontotemporal dementia. Brain. 2011;134(9):2493&#x2013;2501. doi: 10.1093/brain/awr171.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr171</ArticleId><ArticleId IdType="pubmed">21859765</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan M.C., Vucic S., Cheah B.C., et al. Amyotrophic lateral sclerosis. Lancet. 2011;377(9769):942&#x2013;955. doi: 10.1016/S0140-6736(10)61156-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)61156-7</ArticleId><ArticleId IdType="pubmed">21296405</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan M.C., Vucic S., Talbot K., et al. Improving clinical trial outcomes in amyotrophic lateral sclerosis. Nat. Rev. Neurol. 2021;17(2):104&#x2013;118. doi: 10.1038/s41582-020-00434-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-020-00434-z</ArticleId><ArticleId IdType="pmc">PMC7747476</ArticleId><ArticleId IdType="pubmed">33340024</ArticleId></ArticleIdList></Reference><Reference><Citation>Kublaoui B.M., Gemelli T., Tolson K.P., Wang Y., Zinn A.R. Oxytocin deficiency mediates hyperphagic obesity of Sim1 haploinsufficient mice. Mol. Endocrinol. 2008;22(7):1723&#x2013;1734. doi: 10.1210/me.2008-0067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/me.2008-0067</ArticleId><ArticleId IdType="pmc">PMC2453606</ArticleId><ArticleId IdType="pubmed">18451093</ArticleId></ArticleIdList></Reference><Reference><Citation>Kullmann S., Veit R. Resting-State Functional Connectivity of the Human Hypothalamus. Vol 179. first ed. Elsevier B.V.; 2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-12-819975-6.00005-4</ArticleId><ArticleId IdType="pubmed">34225957</ArticleId></ArticleIdList></Reference><Reference><Citation>Kullmann S., Heni M., Linder K., et al. Resting-state functional connectivity of the human hypothalamus. Hum. Brain Mapp. 2014;35(12):6088&#x2013;6096. doi: 10.1002/hbm.22607.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hbm.22607</ArticleId><ArticleId IdType="pmc">PMC6869436</ArticleId><ArticleId IdType="pubmed">25131690</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindauer E., Dupuis L., M&#xfc;ller H.P., Neumann H., Ludolph A.C., Kassubek J. Adipose tissue distribution predicts survival in amyotrophic lateral sclerosis. PLoS One. 2013;8(6):6&#x2013;13. doi: 10.1371/journal.pone.0067783.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0067783</ArticleId><ArticleId IdType="pmc">PMC3694869</ArticleId><ArticleId IdType="pubmed">23826340</ArticleId></ArticleIdList></Reference><Reference><Citation>Malone I.B., Leung K.K., Clegg S., et al. Accurate automatic estimation of total intracranial volume: a nuisance variable with less nuisance. Neuroimage. 2015;104:366&#x2013;372. doi: 10.1016/j.neuroimage.2014.09.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2014.09.034</ArticleId><ArticleId IdType="pmc">PMC4265726</ArticleId><ArticleId IdType="pubmed">25255942</ArticleId></ArticleIdList></Reference><Reference><Citation>Mioshi E., Hsieh S., Savage M.S., Hornberger M.M., Hodges J.R. 2010. Clinical Staging and Disease Progression in Frontotemporal Dementia.</Citation><ArticleIdList><ArticleId IdType="pubmed">20479357</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliver L.D., Stewart C., Coleman K., et al. Neural effects of oxytocin and mimicry in frontotemporal dementia: a randomized crossover study. Neurology. 2020;95(19):e2635&#x2013;e2647. doi: 10.1212/WNL.0000000000010933.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7713736</ArticleId><ArticleId IdType="pubmed">32963103</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker J.A., Bloom S.R. Hypothalamic neuropeptides and the regulation of appetite. Neuropharmacology. 2012;63(1):18&#x2013;30. doi: 10.1016/j.neuropharm.2012.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2012.02.004</ArticleId><ArticleId IdType="pubmed">22369786</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry D.C., Sturm V.E., Seeley W.W., Miller B.L., Kramer J.H., Rosen H.J. Anatomical correlates of reward-seeking behaviours in behavioural variant frontotemporal dementia. Brain. 2014;137(6):1621&#x2013;1626. doi: 10.1093/brain/awu075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awu075</ArticleId><ArticleId IdType="pmc">PMC4032100</ArticleId><ArticleId IdType="pubmed">24740987</ArticleId></ArticleIdList></Reference><Reference><Citation>Piguet O., Peters&#xe9;n &#xc5;., Yin Ka Lam B., et al. Eating and hypothalamus changes in behavioral-variant frontotemporal dementia. Ann. Neurol. 2011;69(2):312&#x2013;319. doi: 10.1002/ana.22244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.22244</ArticleId><ArticleId IdType="pmc">PMC3084499</ArticleId><ArticleId IdType="pubmed">21387376</ArticleId></ArticleIdList></Reference><Reference><Citation>Piguet O., Ahmed R.M., Kumfor F. Oxytocin. 2022. The role of in social circuits and social behavior in dementia; pp. 67&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-0716-1759-5_5</ArticleId><ArticleId IdType="pubmed">34550569</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin C., Li J., Tang K. The paraventricular nucleus of the hypothalamus: development, function, and human diseases. Endocrinology. 2018;159(9):3458&#x2013;3472. doi: 10.1210/en.2018-00453.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/en.2018-00453</ArticleId><ArticleId IdType="pubmed">30052854</ArticleId></ArticleIdList></Reference><Reference><Citation>Rascovsky K., Hodges J.R., Knopman D., et al. Behavioural variant of frontotemporal dementia. Published online. 2011 doi: 10.1093/brain/awr179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr179</ArticleId><ArticleId IdType="pmc">PMC3170532</ArticleId><ArticleId IdType="pubmed">21810890</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton A.E., Majounie E., Waite A., et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72(2):257&#x2013;268. doi: 10.1016/j.neuron.2011.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.010</ArticleId><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Seeley W.W., Menon V., Schatzberg A.F., et al. Dissociable intrinsic connectivity networks for salience processing and executive control. J. Neurosci. 2007;27(9):2349&#x2013;2356. doi: 10.1523/JNEUROSCI.5587-06.2007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.5587-06.2007</ArticleId><ArticleId IdType="pmc">PMC2680293</ArticleId><ArticleId IdType="pubmed">17329432</ArticleId></ArticleIdList></Reference><Reference><Citation>Shapiro N.L., Todd E.G., Billot B., et al. In vivo hypothalamic regional volumetry across the frontotemporal dementia spectrum. Neuroimage Clin. 2022;35(February) doi: 10.1016/j.nicl.2022.103084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2022.103084</ArticleId><ArticleId IdType="pmc">PMC9218583</ArticleId><ArticleId IdType="pubmed">35717886</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw S.R., El-Omar H., Roquet D., et al. Uncovering the prevalence and neural substrates of anhedonia in frontotemporal dementia. Brain. 2021;144(5):1551&#x2013;1564. doi: 10.1093/brain/awab032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab032</ArticleId><ArticleId IdType="pubmed">33843983</ArticleId></ArticleIdList></Reference><Reference><Citation>Shefner J.M., Al-Chalabi A., Baker M.R., et al. A proposal for new diagnostic criteria for ALS. Clin. Neurophysiol. 2020;131(8):1975&#x2013;1978. doi: 10.1016/j.clinph.2020.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2020.04.005</ArticleId><ArticleId IdType="pubmed">32387049</ArticleId></ArticleIdList></Reference><Reference><Citation>Strong M.J., Abrahams S., Goldstein L.H., et al. Amyotrophic lateral sclerosis-frontotemporal spectrum disorder (ALS-FTSD): revised diagnostic criteria. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18(3&#x2013;4):153&#x2013;174. doi: 10.1080/21678421.2016.1267768.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2016.1267768</ArticleId><ArticleId IdType="pmc">PMC7409990</ArticleId><ArticleId IdType="pubmed">28054827</ArticleId></ArticleIdList></Reference><Reference><Citation>Tombaugh T.N. Trail making test A and B: normative data stratified by age and education. Arch. Clin. Neuropsychol. 2004;19(2):203&#x2013;214. doi: 10.1016/S0887-6177(03)00039-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0887-6177(03)00039-8</ArticleId><ArticleId IdType="pubmed">15010086</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Der Klaauw A.A., Farooqi I.S. The hunger genes: pathways to obesity. Cell. 2015;161(1):119&#x2013;132. doi: 10.1016/j.cell.2015.03.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.03.008</ArticleId><ArticleId IdType="pubmed">25815990</ArticleId></ArticleIdList></Reference><Reference><Citation>Vercruysse P., Sinniger J., El Oussini H., et al. Alterations in the hypothalamic melanocortin pathway in amyotrophic lateral sclerosis. Brain. 2016;139(4):1106&#x2013;1122. doi: 10.1093/brain/aww004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aww004</ArticleId><ArticleId IdType="pubmed">26984187</ArticleId></ArticleIdList></Reference><Reference><Citation>Vercruysse P., Vieau D., Blum D., Peters&#xe9;n &#xc5;., Dupuis L. Hypothalamic alterations in neurodegenerative diseases and their relation to abnormal energy metabolism. Front. Mol. Neurosci. 2018;11(January):1&#x2013;16. doi: 10.3389/fnmol.2018.00002.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2018.00002</ArticleId><ArticleId IdType="pmc">PMC5780436</ArticleId><ArticleId IdType="pubmed">29403354</ArticleId></ArticleIdList></Reference><Reference><Citation>Wedderburn C., Wear H., Brown J., et al. The utility of the Cambridge behavioural inventory in neurodegenerative disease. J. Neurol. Neurosurg. Psychiatry. 2008;79(5):500&#x2013;503. doi: 10.1136/jnnp.2007.122028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2007.122028</ArticleId><ArticleId IdType="pubmed">17846114</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>